Cerebrovascular disease - Advances in management

Hong Kong Medical Journal

Volumn 7, Issue 1, 2001, Pages 58-66

  Cheung, R T F ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cerebral haemorrhage; Cerebral infarction; Subarachnoid haemorrhage; Surgical treatment; Thrombolysis

Indexed keywords

ALTEPLASE; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; HEPARIN; PROUROKINASE; VIPER VENOM;

ARTIFICIAL VENTILATION; BRAIN EDEMA; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; EARLY DIAGNOSIS; HUMAN; HYDROCEPHALUS; HYPOVENTILATION; NEUROLOGICAL COMPLICATION; SYSTEMIC DISEASE; TREATMENT INDICATION; TREATMENT OUTCOME;

ANTICOAGULANTS; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISORDERS; HUMANS; PLATELET AGGREGATION INHIBITORS; SUBARACHNOID HEMORRHAGE; THROMBOLYTIC THERAPY;

EID: 0034882653     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (56)

1. Epidemiology of stroke
2. Guidelines for the management of transient ischemic attacks
3. Intracerebral haemorrhage
4. Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association
5. Cerebrovascular disease in Hong Kong Chinese
6. Stroke subtypes among Chinese living in Hong Kong: The Shatin Stroke Registry
7. Circadian variation of stroke onset in Hong Kong Chinese: A hospital-based study
8. Post-stroke rehabilitation. A review of the guidelines for patient management
9. Primary and secondary prevention of stroke
10. Cardiology
11. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association
12. Guidelines for the management of spontaneous intracerebral hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association
13. Measurements of acute cerebral infarction: A clinical examination scale
14. Collaborative systemic review of the randomised trials of organised inpatient (stroke unit) care after stroke
15. Stroke unit management. Long-term effects
16. Guidelines for Thrombolytic Therapy for Acute Stroke: A Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association
17. CT perfusion study in acute stroke management
18. High dose steroid treatment in cerebral infarction
19. Effects of dexamethasone in primary supratentorial intracerebral hemorrhage
20. Hypothermia as a potential treatment for cerebral ischemia
21. Pathophysiology of acute ischaemic stroke
22. Tissue plasminogen activator for acute ischemic stroke
23. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)
24. Randomised doubleblind placebo-controlled trial of thrombolytic therapy with intra-venous alteplase in acute ischaemic stroke (ECASS II)
25. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke
26. Thrombolytic therapy with streptokinase in acute ischemic stroke
27. Streptokinase for acute ischemic stroke with relationship to time of administration
28. Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial
29. Effects of tissue plasminogen activator for acute ischemic stroke at one year
30. Intravenous tissue-type plasminogen activator for treatment of acute stroke: The Standard Treatment with Alteplase to Reverse Stroke (STARS) study
31. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: A randomized controlled trial
32. tPA in acute ischemic stroke: United States experience and issues for the future
33. Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome
34. Intra-arterial thrombolysis in acute ischaemic stroke: Experience with a superselective catheter embedded in the clot
35. PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery. Stroke
36. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial
37. Combined intravenous and intra-arterial r-tPA versus intraarterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial
38. Recruitment of stroke patients for acute therapy in Hong Kong - Experience from a teaching hospital
39. Intravenous ancrod for treatment of acute ischemic stroke: The STAT study: A randomized controlled trial. Stroke Treatment with Ancrod Trial
40. Hemorrhagic infarcts
41. Hemorrhagic cerebral infarction - A prospective study
42. The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke
43. Low-molecular-weight heparin for the treatment of acute ischemic stroke
44. Fraxiparine in ischaemic stroke study (FISS bis)
45. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: A randomized controlled trial
46. Low-molecular-weight heparins and heparinoids in acute ischemic stroke: A metaanalysis of randomized controlled trials
47. CAST: Randomised placebo-controlled trial of early aspirin use in 20000 patients with acute ischaemic stroke
48. Abciximab in acute ischemic stroke: A randomized, double-blind, placebo-controlled, dose-escalation study
49. Fatal hemorrhagic transformation of acute cerebral infarction after the use of abciximab
50. Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: A randomised controlled trial
51. Major ongoing stroke trials
52. Decompressive surgery in space-occupying hemispheric infarction: Results of an open, prospective trial
53. Aneurysmal rebleeding: A preliminary report from the Cooperative Aneurysm Study
54. Cerebral vasospasm after subarachnoid haemorrhage: An update
55. Knowledge of stroke in Hong Kong Chinese
56. Influence of patients' knowledge of stroke on time to presentation in Hong Kong